{"id":69558,"name":"HIV AND HEPATITIS POLICY INSTITUTE","slug":"hiv-and-hepatitis-policy-institute","state":"DC","country":"United States of America","description":"Patient advocacy","totalSpending":30000,"filings":2,"yearlySpending":[{"year":2025,"income":30000}],"issues":[{"code":"BUD","display":"Budget/Appropriations"},{"code":"HCR","display":"Health Issues"},{"code":"INS","display":"Insurance"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"}],"firms":["KAMRAN DARAVI CONSULTING LLC"],"lobbyists":["KAMRAN DARAVI"],"govEntities":["Centers For Disease Control & Prevention (CDC)","Centers For Medicare and Medicaid Services (CMS)","Health & Human Services, Dept of (HHS)","Health Resources & Services Administration (HRSA)","Natl Institutes of Health (NIH)"],"sampleDescriptions":["Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.","Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.","Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.","Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs.","Lobbying for domestic HIV prevention and treatment, viral hepatitis and patient access and affordability of prescription drugs."]}